Rhelion Life Sciences' subsidiary Filament Health Corp. participated in the FDA public hearing on September 14, 2026, discussing the potential future therapeutic use of psychedelic drugs. Filament's president, Sarit Hashkes, provided oral remarks highlighting their expertise and readiness to support regulated access pathways for psilocybin-based treatments like their patented drug candidate PEX010. The hearing aims to gather input on developing and evaluating psychedelic therapies, with Filament contributing to this important dialogue. This marks a significant step as the FDA explores regulatory frameworks for psychedelic medicines in the U.S.
Rhelion Life Sciences' subsidiary Filament Health's participation in the FDA hearing on psychedelic drug therapies is noted here with Pluang's Health sector market data as of Sep 14, 2026 18:52 WIB. Of 91 priced Health-sector US stocks tradable on Pluang, 50 rose and 28 fell today. Notable movers include Sanofi SA (SNY) at USD 43.50 with a 1-day change of +1.71%, Alcon AG (ALC) at USD 67.13 up +1.67%, and Inovio Pharmaceuticals Inc (INO) at USD 1.23 down -1.60%.
CIQ has released Fuzzball 4.3, a platform that enables enterprises to deploy validated open-weight AI models and agents on their existing GPU infrastructure with a single command. This update simplifies operationalizing AI by automatically connecting...
As of September 30, 2026, Societe Generale's share capital consists of 739,264,232 shares with a total of 821,169,560 voting rights. The bank highlights its strong global presence with 110,000 employees serving 27 million clients across 58 countries....
Weyerhaeuser's stock recently dropped to a new 52-week low of $18.31, trading around $18.51, reflecting market pressure. Analysts have mixed views: Seaport Global lowered its price target to $30, Raymond James upgraded to "strong buy" with the same t...
Canadian Utilities and Emera have agreed to merge as equals, creating a larger utility and energy infrastructure company. RBC Capital maintains a 'Sector Perform' rating on Canadian Utilities, indicating expected performance in line with the sector. ...
Domino's Pizza is set to report its Q3 earnings on October 13, 2026, with analysts forecasting earnings per share between $4.33 and $4.36 and revenue around $1.17 billion, a 1.6% increase year-over-year. Investors will watch closely how promotional d...
